Gabapentin used for anxiety
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin for Anxiety: A Comprehensive Review
Introduction to Gabapentin and Its Uses
Gabapentin, originally developed as an anticonvulsant, has found a variety of off-label uses in the treatment of psychiatric disorders, including anxiety. Despite its primary indications for conditions like postherpetic neuralgia and partial-onset seizures, gabapentin is frequently prescribed for anxiety disorders due to its favorable side effect profile and minimal drug interactions1 4.
Efficacy of Gabapentin in Treating Anxiety Disorders
Generalized Anxiety Disorder (GAD)
Gabapentin has shown promise in treating Generalized Anxiety Disorder (GAD). Although there are no large-scale randomized controlled trials (RCTs) specifically for GAD, case reports and smaller studies suggest its effectiveness. For instance, a case study highlighted a clear dose-response relationship in a patient with GAD, indicating that gabapentin could be a viable treatment option7. Additionally, gabapentin has been noted to be effective in reducing anxiety symptoms in breast cancer survivors, further supporting its potential use in GAD5 8.
Social Anxiety Disorder and Panic Disorder
Gabapentin has also been investigated for its efficacy in social anxiety disorder and panic disorder. The evidence is somewhat mixed but generally positive. Some studies have shown that gabapentin can be effective in reducing symptoms of social anxiety, making it a potential alternative for patients who do not respond well to traditional anxiolytics4 9. However, more extensive research is needed to draw definitive conclusions.
Preoperative Anxiety and Anxiety in Cancer Patients
Gabapentin has been found to be particularly effective in managing preoperative anxiety and anxiety in breast cancer survivors. A randomized controlled trial demonstrated that gabapentin significantly reduced anxiety levels in breast cancer patients, with the lower dose (300 mg) showing the best outcomes5. This finding is corroborated by another study that reported a reduction in anxiety among cancer patients treated with gabapentin8.
Comparative Analysis with Other Treatments
Gabapentin vs. Pregabalin
Gabapentin and pregabalin are structurally similar and share a mechanism of action, binding to a subunit of voltage-dependent calcium channels. Both drugs have been used off-label for anxiety disorders, but pregabalin is currently approved for the treatment of generalized anxiety disorder (GAD) by the European Medicines Agency, unlike gabapentin4. Comparative studies suggest that while both drugs are effective, pregabalin may have a slight edge in terms of regulatory approval and specific indications for anxiety4.
Gabapentin as an Adjunctive Therapy
Gabapentin is often used as an adjunctive therapy rather than a monotherapy for anxiety disorders. It has been shown to be effective when combined with other treatments, such as antidepressants, particularly in patients who do not fully respond to standard treatments1 3. This makes gabapentin a valuable option for enhancing the efficacy of existing treatment regimens.
Safety and Tolerability
Gabapentin is generally well-tolerated, with a favorable side effect profile. It does not require therapeutic drug monitoring and has minimal drug interactions, making it a safer option for long-term use compared to some other anxiolytics6. This is particularly beneficial for patients with a history of substance use, as gabapentin does not carry the same risk of addiction or abuse as benzodiazepines5.
Conclusion
Gabapentin shows considerable promise as a treatment for various anxiety disorders, including GAD, social anxiety disorder, and preoperative anxiety. While more extensive and well-designed studies are needed to fully establish its efficacy, current evidence suggests that gabapentin can be an effective and safe option, particularly as an adjunctive therapy. Its minimal side effects and low risk of addiction make it a valuable alternative for patients who are reluctant to use traditional anxiolytics.
Sources and full results
Most relevant research papers on this topic